IWM
GILD icon

Iams Wealth Management’s Gilead Sciences GILD Stock Holding History

Iams Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
25,186
+3,780
+18% +$498K 0.96% 30
2026
Q1 		$2.98M Sell
21,406
-3,275
-13% -$459K 1.04% 23
2025
Q4 		$3.03M Sell
24,681
-620
-2% -$75.3K 1.09% 19
2025
Q3 		$2.81M Buy
25,301
+1,880
+8% +$214K 1.13% 20
2025
Q2 		$2.6M Sell
23,421
-759
-3% -$80.8K 1.19% 20
2025
Q1 		$2.71M Sell
24,180
-3,630
-13% -$375K 1.24% 18
2024
Q4 		$2.57M Sell
27,810
-2,360
-8% -$212K 1.17% 22
2024
Q3 		$2.53M Buy
30,170
+809
+3% +$61.7K 1.24% 16
2024
Q2 		$2.01M Buy
29,361
+8,752
+42% +$584K 1.1% 21
2024
Q1 		$1.5M Buy
20,609
+167
+0.8% +$12.8K 0.92% 36
2023
Q4 		$1.66M Sell
20,442
-1,105
-5% -$86K 1.07% 28
2023
Q3 		$1.61M Buy
+21,547
New +$1.66M 1.12% 29
2023
Q2 		– Sell
-17,227
Closed -$1.37M – 176
2023
Q1 		$1.4M Buy
17,227
+6,145
+55% +$509K 1.17% 18
2022
Q4 		$951K Buy
+11,082
New +$878K 0.97% 27

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Iams Wealth Management's GILD Position: Q2 2026 in Review

Iams Wealth Management increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $498K and bringing the position to 25,186 shares worth $3.18M. The position accounts for 0.96% of the portfolio, ranked #30.

Iams Wealth Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Iams Wealth Management held 25,186 shares of Gilead Sciences worth $3.18M as of Q2 2026.
  • Iams Wealth Management bought 3,780 Gilead Sciences shares in Q2 2026, an estimated $498K.
  • Gilead Sciences made up 0.96% of Iams Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Iams Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Iams Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.